Search alternatives:
progress » process (Expand Search)
Showing 1,341 - 1,360 results of 12,642 for search 'detection (progress OR programs)', query time: 0.21s Refine Results
  1. 1341

    Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients by M. V. Solovev, L. P. Mendeleeva, G. A. Yatsyk, N. S. Lutsik, M. V. Firsova, E. G. Gemdzhian, V. G. Savchenko

    Published 2019-01-01
    “…The study of influence of residual tumor mass, determined by magnetic resonance imaging (MRI), on the progression-free survival (PFS) remains an actual problem. …”
    Get full text
    Article
  2. 1342

    New-Onset Progressive Ataxia in a 66-Year-Old Woman with Longstanding Parkinson’s Disease: A Case Report by Lukas Gattermeyer-Kell, Petra Katschnig-Winter, Mariella Kögl, Petra Schwingenschuh

    Published 2025-03-01
    “…No apparent dural leak was detected in cerebrospinal fluid scintigraphy. The patient was treated with epidural blood patch. …”
    Get full text
    Article
  3. 1343

    Prognostic value of Linc00662/miR-16-5p/FASN in cervical cancer and regulation of tumor progression by Yu Yang, Zhanping Guo

    Published 2025-08-01
    “…The goal of the work was to investigate the expression, prognostic value and biological utility of Linc00662 in CC progression and to identify its underlying mechanisms in molecular terms. …”
    Get full text
    Article
  4. 1344
  5. 1345
  6. 1346

    LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis by Li Chunxia, Zhang Lihui, Bu Xingpeng, Chu Guofang, Zhao Xiaofang, Liu Yaru

    Published 2022-04-01
    “…Taken together, our study reveals that NORAD promotes the progression of AMI by regulating the miR-22-3p/PTEN axis, and the AKT/mTOR signaling may also be involved in the regulatory processes.…”
    Get full text
    Article
  7. 1347

    KLF13 promotes esophageal cancer progression and regulates triacylglyceride and free fatty acid metabolism through GPIHBP1 by Pengjie Yang, Benben Zhu, Hongwei Cui, Yongjun Yu, Qin Yu, Linghui Kong, Mengfei Sun, Yuan Liu, Bateer Han, Shuchen Chen

    Published 2025-05-01
    “…Abstract Kruppel-Like Factor 13 (KLF13) has strong effects on cancer occurrence and progression. Nevertheless, the role of KLF13 in oesophagal cancer (EC) remain elusive. …”
    Get full text
    Article
  8. 1348
  9. 1349
  10. 1350

    Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis by Désirée van der Heijde, Yoshiya Tanaka, Paul Emery, Li Xie, Michael Schiff, Gabriella Meszaros, Taeko Ishii, Marta Casillas, Robert A Ortmann

    Published 2019-06-01
    “…Linear extrapolation was used for missing data.Results Of 2573 randomised patients, 2125 (82.6%) entered the LTE, of whom 1893 (89.1%) entered this analysis. At year 2, progression was significantly lower with initial baricitinib (monotherapy or combination therapy) versus initial MTX in DMARD-naïve patients (proportion with non-progression defined by ≤smallest detectable change (SDC): 87.3% baricitinib 4 mg+MTX; 70.6% MTX; p≤ 0.001). …”
    Get full text
    Article
  11. 1351

    ROLE OF TRANSFORMING GROWTH FACTOR RECEPTOR B I TYPE (TGF-BRI) IN THE PROGRESSION OF THE LUMINAL BREAST CANCER SUBTYPE by N. N. Babyshkina, S. V. Vtorushin, T. A. Dronova, N. V. Krakhmal, M. V. Zavyalova, M. M. Tsyganov, S. V. Patalyak, E. M. Slonimskaya, N. V. Cherdyntseva

    Published 2017-06-01
    “…The aim of the study was to examine the relationship between the protein and receptor gene expression of transforming growth factor β type I (TGF-βRI) and its polymorphism with progression of luminal breast cancer patients treated by adjuvant tamoxifen. …”
    Get full text
    Article
  12. 1352

    MicroRNA-18b-5p Inhibits the Malignant Progression of Prostate Cancer Through Downregulating TRAF5 by Wang X, Yu X, Wang Y, Lian J, Li Z, Dong C, Song H, Zhang L, Zhang H, Wang Y

    Published 2025-03-01
    “…Overexpression of TRAF5 abolished the suppressive effects of restored miR-18b-5p on PCa cell progression.Conclusion: This study elucidates that upregulated miR-18b-5p impedes PCa cell progression via downregulating TRAF5, which may provide a novel therapeutic basis for PCa. …”
    Get full text
    Article
  13. 1353

    Dermatopontin promotes abdominal aortic aneurysm progression via the IL-1β-COL1A1 axis by YIN Huarun, ZHAO Ning, WU Zhiyuan, LI Yongjun, YIN Hongchao

    Published 2025-07-01
    “…Objective To investigate the expression of dermatopontin (DPT) in abdominal aortic aneurysm (AAA) and to explore the mechanism in promoting AAA progression. Methods Differential gene expression (DEG) and GO-KEGG pathway enrichment were used to assess DPT expression level and related pathways in AAA. …”
    Get full text
    Article
  14. 1354

    The KDM5A/HOXA5 axis regulates osteosarcoma progression via activating the Wnt/β-catenin pathway by Yi Luo, Youzhi He, Yuxia Xu, Yongfu Wang, Li Yang

    Published 2025-04-01
    “…Abstract As an oncogenic driver, lysine-specific demethylase 5A (KDM5A) participates in regulating numerous tumor progression-related processes. Moreover, KDM5A functions as a histone demethylase, modulating the expression levels of its target genes by adjusting methylation levels. …”
    Get full text
    Article
  15. 1355

    Heat shock transcription factor 1 facilitates liver cancer progression by driving super‐enhancer‐mediated transcription of MYCN by Yizhe Liu, Qili Shi, Yue Su, Zhiao Chen, Xianghuo He

    Published 2024-09-01
    “…Moreover, increased MYCN expression was detected in HCC tumors and correlated with unfavorable patient outcomes. …”
    Get full text
    Article
  16. 1356
  17. 1357

    Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2 by Wan W, Pan Y, Pang J, Bai X, Li L, Kang T, Chen J, Wen R, Wen D, Yang H, He Y

    Published 2024-10-01
    “…In the heat-stressed HCC cell model, downregulating FOXP4 inhibited cancer cell progression. Besides, there was a positive association between FOXP4 and NDST2 in liver cancer. …”
    Get full text
    Article
  18. 1358

    COP1 drives renal cell carcinoma progression by targeting ACSL4 for ubiquitin-mediated degradation and inhibiting ferroptosis by Yuxiao Zheng, Lei Jiang, Feng Qi, Bo Peng

    Published 2025-05-01
    “…BackgroundRenal cell carcinoma (RCC) progression is closely linked to dysregulation of the ubiquitin-proteasome system, particularly aberrant ubiquitination processes governing protein degradation and cell cycle control. …”
    Get full text
    Article
  19. 1359

    Clinical values of serum interleukin-17A and interleukin-23 in predicting the occurrence and progression of IgA vasculitis nephritis by Peng Li, Wang Li, Liu Wei-jia, Pan Chun-qin, Liu Jie

    Published 2022-10-01
    “…ObjectiveTo explore the clinical values of serum interleukin 17A (IL-17A) and IL-23 in predicting the occurrence and progression of immunoglobulin A vasculitis (IgAV) complicated with nephritis.MethodsFrom January 2018 to October 2021, 71 IgAV patients were selected along with 50 age/gender-matched healthy volunteers as normal control group. …”
    Get full text
    Article
  20. 1360

    YY1 induced USP13 transcriptional activation drives the malignant progression of hepatocellular carcinoma by deubiquitinating WWP1 by Qingwei Zhu, Zibo Yuan, Qiang Huo, Qiliang Lu, Qingsong Wu, Junwei Guo, Wen Fu, Ying Lu, Lei Zhong, Wenzhong Shang, Di Cui, Shuangshuang Li, Xin Liu, Kangsheng Tu, Dongsheng Huang, Qiuran Xu, Xiaoge Hu

    Published 2025-05-01
    “…Cell Counting Kit-8, colony formation, wound healing, Transwell, and sphere formation assays were used to detect the malignant behaviors of HCC cells in vitro. …”
    Get full text
    Article